Hareesh B. Nair

No ORCID on file · 8 papers in corpus · active 2006-2023

Study types

  • article 7
  • other 1

Condition tags

  • endometriosis 6
  • infertility 1
article 2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1201547

Introduction The pharmacological target for progesterone, different progestins, and Selective Progesterone Receptor Modulators (SPRMs) is the nuclear progesterone receptor (PR). EC313 is a new member of a subgroup of SPRMs, mesoprogestins, …

article 2016
Oncotarget ·doi:10.18632/oncotarget.7516

// Hareesh B. Nair 1 , Robert Baker 2 , Michael A. Owston 2 , Renee Escalona 2 , Edward J. Dick 2 , John L. VandeBerg 2 and Klaus J. Nickisch 1 1 Evestra, Inc., San Antonio, TX, USA 2 Southwest National Primate Research Center, Texas Biomed…

other 2013
Steroids ·doi:10.1016/j.steroids.2013.04.003

Progesterone receptor (PR) plays a key role in reproductive functions, and compounds that inhibit progesterone action (antiprogestins) have potential use in the treatment of estrogen- and progesterone-dependent diseases, including uterine l…

article 2012
Fertility and sterility ·doi:10.1016/j.fertnstert.2012.02.007
article 2012
·doi:10.4172/2161-0932.1000e105

Endometriosis is a painful gynecological condition in the fertile-age in which presence of endometrial tissue develops outside the uterus, which under normal situation found only in the inside lining of the uterus, attach to pelvic floor, e…

article 2009
Molecular human reproduction ·doi:10.1093/molehr/gap043

Transforming growth factor beta 1 (TGF-beta1) levels are increased in the peritoneal fluid of endometriosis patients, and endometrial cells express TGF-beta signaling components; however, little is known regarding the role of TGF-beta in en…

article 2008
Fertility and sterility ·doi:10.1016/j.fertnstert.2007.09.047
article 2006
·doi:10.1016/j.fertnstert.2006.07.697